Free Trial
NASDAQ:SKYE

Skye Bioscience 8/9/2024 Earnings Report

Skye Bioscience logo
$1.44 -0.15 (-9.18%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$1.44 0.00 (0.00%)
As of 04/17/2025 06:06 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Skye Bioscience EPS Results

Actual EPS
-$0.20
Consensus EPS
-$0.20
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Skye Bioscience Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Skye Bioscience Announcement Details

Quarter
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Skye Bioscience Earnings Headlines

William Blair Comments on Skye Bioscience Q1 Earnings
[Action Required] Claim Your FREE IRS Loophole Guide
This shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the biggest "dollar reset" since 1971.
Analysts Offer Predictions for Skye Bioscience Q2 Earnings
Skye Bioscience announces new preclinical data for nimacimab
See More Skye Bioscience Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Skye Bioscience? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Skye Bioscience and other key companies, straight to your email.

About Skye Bioscience

Skye Bioscience (NASDAQ:SKYE), a clinical stage pharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100 used in the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degeneration and diabetic retinopathy. It has license agreement with university of Mississippi. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. The company is headquartered in San Diego, California.

View Skye Bioscience Profile

More Earnings Resources from MarketBeat